If we choose your letter for publication, we will call you to verify authorship. You can reach us by telephone at 303-954-1331. You may also email your letter to [email protected].

Germany-headquartered CureVac (Nasdaq: CVAC) late Thursday announced that the European Patent Office (EPO) has confirmed the validity of CureVac's European patent EP 3 708 668 B1 subject to amendments ...